Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant Staphylococcus aureus agents using a rat model of sepsis

References

• Aboyoussef AM, Mohammad MK, Abo-Saif AA, Messiha BAS. 2021. Granisetron attenuates liver injury and inflammation in a rat model of cecal ligation and puncture-induced sepsis. J Pharmacol Sci. 147(4):358–366.
   PubMed Web of Science ®Google Scholar
• Barrasa H, Soraluce A, Isla A, Martín A, Maynar J, Canut A, Sánchez-Izquierdo JA, Rodríguez-Gascón A. 2019. Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: influence of residual renal function on PK/PD target attainment. J Crit Care. 50:69–76.
   PubMed Web of Science ®Google Scholar
• Barrasa H, Soraluce A, Usón E, Sainz J, Martín A, Sánchez-Izquierdo JÁ, Maynar J, Rodríguez-Gascón A, Isla A. 2020. Impact of augmented renal clearance on the pharmacokinetics of linezolid: advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective. Int J Infect Dis. 93:329–338.
   PubMed Web of Science ®Google Scholar
• Blanchard AC, Fortin E, Laferrière C, Goyer I, Moussa A, Autmizguine J, Quach C. 2017. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit. J Antimicrob Chemother. 72(6):1812–1817.
   PubMed Web of Science ®Google Scholar
• Bouza E, Muñoz P. 2001. Linezolid: pharmacokinetic characteristics and clinical studies. Clin Microbiol Infect. 7(Suppl 4):75–82.
   PubMed Web of Science ®Google Scholar
• Britt NS, Patel N, Shireman TI, El Atrouni WI, Horvat RT, Steed ME. 2017. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 72(2):535–542.
   PubMed Web of Science ®Google Scholar
• Dryden MS. 2011. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. J Antimicrob Chemother. 66(Supplement 4):iv7–iv15.
   PubMed Web of Science ®Google Scholar
• Dyson A, Singer M. 2009. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med. 37(1 Suppl):S30–S37.
   PubMed Web of Science ®Google Scholar
• Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, Kakihana Y, Kawasaki T, Kushimoto S, Kuroda Y, et al. 2021. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J Intensive Care. 9(1):53.
   PubMed Web of Science ®Google Scholar
• Estes KS, Derendorf H. 2010. Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin. Eur J Med Res. 15(12):533–543.
   PubMed Web of Science ®Google Scholar
• Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC, Reinhart K. 2016. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 193(3):259–272.
   PubMed Web of Science ®Google Scholar
• Holmes NE, Johnson PD, Howden BP. 2012. Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections. J Clin Microbiol. 50(8):2548–2552.
   PubMed Web of Science ®Google Scholar
• Hort M, Bertsche U, Nozinovic S, Dietrich A, Schrötter AS, Mildenberger L, Axtmann K, Berscheid A, Bierbaum G. 2021. The role of β-glycosylated wall teichoic acids in the reduction of vancomycin susceptibility in vancomycin-intermediate Staphylococcus aureus. Microbiol Spectr. 9(2):e0052821.
   PubMed Web of Science ®Google Scholar
• Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, et al. 2015. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 41(8):1411–1423.
   PubMed Web of Science ®Google Scholar
• Ito Y, Inagaki Y, Kobuchi S, Takada K, Sakaeda T. 2016. Therapeutic drug monitoring of vancomycin in dermal interstitial fluid using dissolving microneedles. Int J Med Sci. 13(4):271–276.
   PubMed Web of Science ®Google Scholar
• Kato H, Hagihara M, Asai N, Shibata Y, Koizumi Y, Yamagishi Y, Mikamo H. 2021. Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus. J Glob Antimicrob Resist. 24:98–105.
   PubMed Web of Science ®Google Scholar
• Kim A, Suecof LA, Sutherland CA, Gao L, Kuti JL, Nicolau DP. 2008. In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers. Antimicrob Agents Chemother. 52(11):3941–3946.
   PubMed Web of Science ®Google Scholar
• Kobuchi S, Aoki M, Inoue C, Murakami H, Kuwahara A, Nakamura T, Yasui H, Ito Y, Takada K, Sakaeda T. 2016. Transport of azithromycin into extravascular space in rats. Antimicrob Agents Chemother. 60(11):6823–6827.
   PubMed Web of Science ®Google Scholar
• Kobuchi S, Fujita A, Kato A, Kobayashi H, Ito Y, Sakaeda T. 2020. Pharmacokinetics and lung distribution of macrolide antibiotics in sepsis model rats. Xenobiotica. 50(5):552–558.
   PubMed Web of Science ®Google Scholar
• Kobuchi S, Kabata T, Maeda K, Ito Y, Sakaeda T. 2020. Pharmacokinetics of macrolide antibiotics and transport into the interstitial fluid: comparison among erythromycin, clarithromycin, and azithromycin. Antibiotics (Basel). 9(4):199.
   PubMed Web of Science ®Google Scholar
• Kobuchi S, Kita Y, Hiramatsu Y, Sasaki K, Uno T, Ito Y, Sakaeda T. 2021. Comparison of in vivo transportability of anti-methicillin-resistant Staphylococcus aureus (MRSA) agents into intracellular and extracellular tissue spaces in rats. J Pharm Sci. 110(2):898–904.
   PubMed Web of Science ®Google Scholar
• Okada K, Kimura T, Mikamo H, Kasahara K, Seki M, Takakura S, Tokimatsu I, Ohmagari N, Takahashi Y, Matsumoto K, et al. 2014. Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of chemotherapy and the Japanese Society of therapeutic drug monitoring. J Infect Chemother. 20(1):1–5.
   PubMed Web of Science ®Google Scholar
• Olguner CG, Koca U, Altekin E, Ergür BU, Duru S, Girgin P, Taşdöğen A, Gündüz K, Güzeldağ S, Akkuş M, et al. 2013. Ischemic preconditioning attenuates lipid peroxidation and apoptosis in the cecal ligation and puncture model of sepsis. Exp Ther Med. 5(6):1581–1588.
   PubMed Web of Science ®Google Scholar
• Riedemann NC, Guo RF, Ward PA. 2003. The enigma of sepsis. J Clin Invest. 112(4):460–467.
   PubMed Web of Science ®Google Scholar
• Ritter C, Andrades M, Frota Júnior ML, Bonatto F, Pinho RA, Polydoro M, Klamt F, Pinheiro CT, Menna-Barreto SS, Moreira JC, et al. 2003. Oxidative parameters and mortality in sepsis induced by cecal ligation and perforation. Intensive Care Med. 29(10):1782–1789.
   PubMed Web of Science ®Google Scholar
• Roberts JA, Lipman J. 2009. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med. 37(3):840–859.
   PubMed Web of Science ®Google Scholar
• Rudiger A, Stotz M, Singer M. 2008. Cellular processes in sepsis. Swiss Med Wkly. 138(43-44):629–634.
   PubMed Web of Science ®Google Scholar
• Sakamoto Y, Yano T, Hanada Y, Takeshita A, Inagaki F, Masuda S, Matsunaga N, Koyanagi S, Ohdo S. 2017. Vancomycin induces reactive oxygen species-dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells. Eur J Pharmacol. 800:48–56.
   PubMed Web of Science ®Google Scholar
• Schweizer ML, Richardson K, Vaughan Sarrazin MS, Goto M, Livorsi DJ, Nair R, Alexander B, Beck BF, Jones MP, Puig-Asensio M, et al. 2021. Comparative effectiveness of switching to daptomycin versus remaining on vancomycin among patients with Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections. Clin Infect Dis. 72(Suppl 1):S68–S73.
   PubMed Web of Science ®Google Scholar
• Selmi V, Loriga B, Vitali L, Carlucci M, Di Filippo A, Carta G, Sgambati E, Tofani L, De Gaudio AR, Novelli A, et al. 2016. Changes in ceftriaxone pharmacokinetics/pharmacodynamics during the early phase of sepsis: a prospective, experimental study in the rat. J Transl Med. 14(1):316.
   PubMed Web of Science ®Google Scholar
• Sukkummee W, Jittisak P, Wonganan P, Wittayalertpanya S, Chariyavilaskul P, Leelahavanichkul A. 2019. The prominent impairment of liver/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison. Ren Fail. 41(1):314–325.
   PubMed Web of Science ®Google Scholar
• Tanaka R, Kai M, Goto K, Ohchi Y, Yasuda N, Tatsuta R, Kitano T, Itoh H. 2021. High-throughput and wide-range simultaneous determination of linezolid, daptomycin and tedizolid in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry. J Pharm Biomed Anal. 194:113764.
   PubMed Web of Science ®Google Scholar
• Udy AA, Putt MT, Boots RJ, Lipman J. 2011. ARC–augmented renal clearance. Curr Pharm Biotechnol. 12(12):2020–2029.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Zhou X, Dai Q, Fan Y, Huang X. 2015. Hydrogen-rich saline ameliorates lung injury associated with cecal ligation and puncture-induced sepsis in rats. Exp Mol Pathol. 98(2):268–276.
   PubMed Web of Science ®Google Scholar